SPI vs. ONT, GNS, CRW, UPR, PRTC, AMS, BMK, MXCT, NIOX, and OXB
Should you be buying Spire Healthcare Group stock or one of its competitors? The main competitors of Spire Healthcare Group include Oxford Nanopore Technologies (ONT), Genus (GNS), Craneware (CRW), Uniphar (UPR), PureTech Health (PRTC), Advanced Medical Solutions Group (AMS), Benchmark (BMK), MaxCyte (MXCT), NIOX Group (NIOX), and Oxford Biomedica (OXB). These companies are all part of the "medical" sector.
Spire Healthcare Group (LON:SPI) and Oxford Nanopore Technologies (LON:ONT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings, community ranking, valuation and media sentiment.
44.8% of Spire Healthcare Group shares are owned by institutional investors. Comparatively, 38.4% of Oxford Nanopore Technologies shares are owned by institutional investors. 34.5% of Spire Healthcare Group shares are owned by insiders. Comparatively, 30.1% of Oxford Nanopore Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Spire Healthcare Group has a beta of 0.99, meaning that its stock price is 1% less volatile than the S&P 500. Comparatively, Oxford Nanopore Technologies has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500.
Spire Healthcare Group received 327 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 60.82% of users gave Spire Healthcare Group an outperform vote.
In the previous week, Oxford Nanopore Technologies had 5 more articles in the media than Spire Healthcare Group. MarketBeat recorded 5 mentions for Oxford Nanopore Technologies and 0 mentions for Spire Healthcare Group. Oxford Nanopore Technologies' average media sentiment score of 1.27 beat Spire Healthcare Group's score of 0.00 indicating that Oxford Nanopore Technologies is being referred to more favorably in the news media.
Spire Healthcare Group has a net margin of 2.01% compared to Oxford Nanopore Technologies' net margin of -91.06%. Spire Healthcare Group's return on equity of 3.81% beat Oxford Nanopore Technologies' return on equity.
Spire Healthcare Group has higher revenue and earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.
Spire Healthcare Group presently has a consensus price target of GBX 302.25, suggesting a potential upside of 21.88%. Oxford Nanopore Technologies has a consensus price target of GBX 303.75, suggesting a potential upside of 175.89%. Given Oxford Nanopore Technologies' higher possible upside, analysts clearly believe Oxford Nanopore Technologies is more favorable than Spire Healthcare Group.
Summary
Spire Healthcare Group beats Oxford Nanopore Technologies on 11 of the 17 factors compared between the two stocks.
Get Spire Healthcare Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for SPI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SPI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Spire Healthcare Group Competitors List
Related Companies and Tools
